Medline, Inc. (MDLN)
35.93
+0.48
(+1.35%)
USD |
NASDAQ |
Oct 08, 15:24
Medline EPS Diluted (Quarterly) : 0.0697 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0697 |
| March 31, 2026 | 0.1564 |
| December 31, 2025 | 0.2241 |
| September 30, 2025 | 0.4026 |
| June 30, 2025 | 0.4164 |
| Date | Value |
|---|---|
| March 31, 2025 | 0.4026 |
| December 31, 2024 | 0.3613 |
| September 30, 2024 | 0.4051 |
| June 30, 2024 | 0.3651 |
| March 31, 2024 | 0.3688 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insulet Corp. | 1.066 |
| Abbott Laboratories | 0.5324 |
| AngioDynamics, Inc. | -0.2735 |
| Alphatec Holdings, Inc. | -0.1647 |
| AtriCure, Inc. | 0.1832 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 139.00M |
| Revenue (Quarterly) | 7.685B |
| Total Expenses (Quarterly) | 7.625B |
| Enterprise Value | 48.56B |
| Gross Profit Margin (Quarterly) | 26.52% |
| Profit Margin (Quarterly) | 1.81% |
| Earnings Yield | 2.37% |
| Operating Earnings Yield | 6.57% |
| Normalized Earnings Yield | 3.744 |